Clinical trial
Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized…
NCT00224315 · Central Institute of Mental Health, Mannheim, Other · Completed
Key facts
| NCT number | NCT00224315 |
|---|---|
| Title | Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial |
| Official title | Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial |
| Lead sponsor | Central Institute of Mental Health, Mannheim, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | ziprasidone, risperidone |
| Enrollment | 24 |
| Start date | Nov 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 4, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: